Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ritonavir. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of Ritonavir using Valine NCA improves atom economy and purity. A reliable ritonavir intermediate supplier offering cost-effective manufacturing solutions.
Patent CN104693140A details high-purity purification for ritonavir intermediates ensuring supply chain reliability and significant cost reduction in pharmaceutical intermediates manufacturing.
Novel 7-step route for D6-Ritonavir using isobutyric acid-D6. Achieves >98% purity and >99% isotope abundance for metabolic studies.
Patent CN111393329A details a high-yield synthesis of BDH, a key ritonavir intermediate, utilizing stereoselective reduction for cost-effective manufacturing.